These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23830871)

  • 1. Learning from rejection: what transplantation teaches us about (other) vascular pathologies.
    Mitchell RN
    J Autoimmun; 2013 Sep; 45():80-9. PubMed ID: 23830871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular remodeling in transplant vasculopathy.
    Mitchell RN; Libby P
    Circ Res; 2007 Apr; 100(7):967-78. PubMed ID: 17431198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft vascular disease: immune response meets the vessel wall.
    Mitchell RN
    Annu Rev Pathol; 2009; 4():19-47. PubMed ID: 18717641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allograft arteriopathy: pathogenesis update.
    Mitchell RN
    Cardiovasc Pathol; 2004; 13(1):33-40. PubMed ID: 14761783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody.
    Galvani S; Trayssac M; Augé N; Thiers JC; Calise D; Krell HW; Sallusto F; Kamar N; Rostaing L; Thomsen M; Nègre-Salvayre A; Salvayre R
    Circulation; 2011 Dec; 124(24):2725-34. PubMed ID: 22082680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
    Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
    PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemokines in transplant graft arterial disease.
    Shimizu K; Mitchell RN
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1937-49. PubMed ID: 18802020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic rejection in experimental cardiac transplantation in a rat model.
    Karnovsky MJ; Russell ME; Hancock W; Sayegh MH; Adams DH
    Clin Transplant; 1994 Jun; 8(3 Pt 2):308-12. PubMed ID: 8061372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
    Fuster V; Charlton P; Boyd A
    Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy.
    Shimizu K; Sugiyama S; Aikawa M; Fukumoto Y; Rabkin E; Libby P; Mitchell RN
    Nat Med; 2001 Jun; 7(6):738-41. PubMed ID: 11385513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of human smooth muscle cell proliferation and transplant vasculopathy induced by HLA class I antibodies: in vitro and in vivo studies.
    Trayssac M; Nègre-Salvayre A; Thomsen M
    Hum Immunol; 2012 Dec; 73(12):1253-60. PubMed ID: 22789624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
    Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
    Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
    Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
    J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allograft-induced proliferation of vascular smooth muscle cells: potential targets for treating transplant vasculopathy.
    Autieri MV
    Curr Vasc Pharmacol; 2003 Mar; 1(1):1-9. PubMed ID: 15320847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic allograft rejection associated vasculopathy and synthetic biodegradable vascular grafts: a lesson to learn?
    Nieuwenhuis P; Hillebrands JL; Rozing J
    Crit Rev Immunol; 2000; 20(1):85-8. PubMed ID: 10770271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoluminal smooth muscle cell seeding limits intimal hyperplasia.
    Gomes D; Louedec L; Plissonnier D; Dauge MC; Henin D; Osborne-Pellegrin M; Michel JB
    J Vasc Surg; 2001 Oct; 34(4):707-15. PubMed ID: 11668328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft vasculopathy versus atherosclerosis.
    Rahmani M; Cruz RP; Granville DJ; McManus BM
    Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.
    Sabet-Baktach M; Eggenhofer E; Rovira J; Renner P; Lantow M; Farkas SA; Malaisé M; Edtinger K; Shaotang Z; Koehl GE; Dahlke MH; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2013 Oct; 191(8):4440-6. PubMed ID: 24058178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft vasculopathy: current review and future research directions.
    Pober JS; Chih S; Kobashigawa J; Madsen JC; Tellides G
    Cardiovasc Res; 2021 Nov; 117(13):2624-2638. PubMed ID: 34343276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.